OppenheimerFunds’s Kindred Healthcare KND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-476,841
Closed -$4.36M 1840
2018
Q1
$4.36M Sell
476,841
-151,041
-24% -$1.4M 0.01% 778
2017
Q4
$6.09M Sell
627,882
-5,609
-0.9% -$41.7K 0.01% 789
2017
Q3
$4.31M Buy
633,491
+164,453
+35% +$1.4M 0.01% 830
2017
Q2
$5.46M Sell
469,038
-168,272
-26% -$1.66M 0.01% 810
2017
Q1
$5.32M Buy
637,310
+46,250
+8% +$362K 0.01% 834
2016
Q4
$4.64M Buy
591,060
+267,195
+83% +$2.19M 0.01% 839
2016
Q3
$3.31M Buy
323,865
+41,923
+15% +$465K ﹤0.01% 848
2016
Q2
$3.18M Buy
281,942
+23,983
+9% +$300K ﹤0.01% 840
2016
Q1
$3.19M Sell
257,959
-1,395
-0.5% -$14.5K ﹤0.01% 848
2015
Q4
$3.09M Buy
+259,354
New +$3.36M ﹤0.01% 866

Other funds holding KND

OppenheimerFunds's KND Position: Q2 2018 in Review

OppenheimerFunds sold out of Kindred Healthcare (KND) in Q2 2018, closing a stake of 476,841 shares — an estimated $4.36M sold.

OppenheimerFunds first reported a position in KND in Q4 2015 and held it in 10 quarters. The position peaked at $6.09M in Q4 2017. 149 funds tracked by Wall St. Rank hold KND as of Q2 2018.

  • OppenheimerFunds reported no remaining Kindred Healthcare position as of Q2 2018 after selling out during the quarter.
  • OppenheimerFunds sold 476,841 Kindred Healthcare shares in Q2 2018, an estimated $4.36M.
  • OppenheimerFunds first reported a position in Kindred Healthcare in Q4 2015 and held it in 10 quarters.
  • OppenheimerFunds's Kindred Healthcare position peaked at $6.09M in Q4 2017.
  • 149 funds tracked by Wall St. Rank held Kindred Healthcare as of Q2 2018.

Based on OppenheimerFunds's 13F filing for Q2 2018, filed 13 Aug 2018.